(Total Views: 589)
Posted On: 06/06/2019 4:22:09 PM
Post# of 416
NetworkNewsBreaks – Why Endonovo Therapeutics Inc. (ENDV) Is ‘One to Watch’
Endonovo Therapeutics (OTCQB: ENDV) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. A recent article discussing the company reads, “Endonovo Therapeutics develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, noninvasive medical devices are designed to deliver the company’s proprietary, patent protected electroceutical therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (‘CNS’) disorders.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Endonovo Therapeutics (OTCQB: ENDV) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. A recent article discussing the company reads, “Endonovo Therapeutics develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, noninvasive medical devices are designed to deliver the company’s proprietary, patent protected electroceutical therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (‘CNS’) disorders.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
